Transfection of human embryonic stem cells

Details for Australian Patent Application No. 2002247875 (hide)

Owner Yissum Research Development Company of The Hebrew University of Jerusalem

Inventors Benvenisty, Nissim; Eiges-Avner, Rachel; Schuldiner, Maya; Yanuka, Ofra

Agent Davies Collison Cave

Pub. Number AU-B-2002247875

PCT Pub. Number WO2002/061033

Priority 60/253,222 27.11.00 US; 60/267,664 09.02.01 US

Filing date 27 November 2001

Wipo publication date 12 August 2002

Acceptance publication date 6 September 2007

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 35/12 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Materials from mammals or birds

A61K 35/28 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Marrow

A61K 35/30 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Nerves

A61K 35/32 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Bones

A61K 35/34 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Muscles

A61K 35/36 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Skin

A61K 35/44 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Eyes

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 35/00 (2006.01) Antineoplastic agents

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

A61P 37/02 (2006.01) Drugs for immunological or allergic disorders

C12N 5/06 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines -

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/87 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation

C12Q 1/02 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving viable micro-organisms

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

Event Publications

20 February 2003 Application Open to Public Inspection

  Published as AU-B-2002247875

6 September 2007 Application Accepted

  Published as AU-B-2002247875

10 January 2008 Standard Patent Sealed

23 June 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002247876-HERBAL COMPOSITION FOR TREATMENT OF NEURONAL INJURIES AND NEURONAL DEGENERATION, METHODS TO PREPARE THE SAME AND USES THEREOF

2002247874